Aripiprazole Tablet, Orally Disintegrating
Product Images NDC 76483-101

This is a package of Aripiprazole Orally Disintegrating Tablets, USP manufactured by Square Pharmaceuticals Ltd. in Bangladesh. Each tablet contains 10mg of Arpiprazole USP and the package contains 30 tablets. It must be stored in a tight container at 20° to 25°C (68° to 77°F). The pharmacist is required to dispense the accompanying medication guide to each patient. The package insert should be consulted for complete prescribing information. The container should be kept out of the reach of children.*

Each orally disintegrating tablet contains 10 mg of Aripiprazole USP. The tablet also contains 1.12 mg of phenylalanine per tablet, which is a component of aspartame. The usual dosage information can be found in the package insert. The tablets should be stored at 20° to 25°C. The medication should be kept out of the reach of children. The accompanying medication is not available. The tablets are manufactured by an unknown company located in Bangladesh.*

This is a description of a medication called Aripiprazole USP. The medication comes in orally disintegrating tablets that contain 15 mg of Aripiprazole. The medication is dispensed in a tight container and should be kept at a controlled room temperature. Patients should refer to the package insert for complete prescribing information. The medication should be kept out of the reach of children. The tablets contain phenylalanine which is a component of aspartame. The medication is manufactured by Square Pharmaceuticals Ltd. in Bangladesh.*

This is a medication called Aripiprazole USP, which is sold in orally disintegrating tablet form. Each tablet contains 15mg of the medication and has a National Drug Code of 76483-101-01. This medication should be stored at room temperature and kept in a tight container. Phenylketonurics should be aware that each tablet contains 1.68mg of phenylalanine. The usual dosage should be determined by following the instructions provided in the package insert. The medication is manufactured by Square Pharmaceuticals Ltd in Bangladesh.*

This is a description for Aripiprazole Orally Disintegrating Tablets, USP, manufactured by Square Pharmaceuticals Ltd. in Bangladesh. Each orally disintegrating tablet contains 15 mg of Aripiprazole USP and is dispensed in a tight container. The tablets contain 1.68 mg of phenylalanine per tablet, which is a component of aspartame, and are primarily intended for treating various medical conditions. The recommended storage temperature is between 20°C to 25°C. Please see the package insert for complete prescribing information and dose recommendations. Pharmacists are advised to dispense the accompanying medication guide to patients and keep this and all drugs out of the reach of children.*

Each orally disintegrating tablet contains 15 mg of Aripiprazole USP, indicated for the treatment of schizophrenia, bipolar disorder, and depression. The tablets contain a small amount of phenylalanine per tablet and should be kept out of reach of children. The drug should be dispensed in a tight container and stored at controlled room temperature. The usual dosage is mentioned in the package insert. The medication is manufactured by Square Pharmaceuticals Ltd. in Bangladesh.*

Each orally disintegrating tablet of Arpiprazole USP contains 20 mg of the active ingredient. It should be noted that it contains phenylalanine which is a component of aspartame. The usual dosage can be found in the package insert along with complete prescribing information. The tablets should be stored in a container and kept at 20° to 25°C (68" o 77°F) at a controlled room temperature. The medication should be kept out of reach from children. The medication is manufactured by Lo Square Pharmaceuticals Ltd. and dispensed by pharmacists.*

These are orally disintegrating tablets with 20mg Aripiprazole USP per each. They are manufactured by Square Pharmaceuticals Ltd. in Bangladesh and are packaged in a container with 90 tablets. The tablets contain phenylalanine and are not suitable for phenylketonurics. A pharmacist should dispense it with a medication guide for each patient. It is intended for prescription only and should be kept in a tight container at 20° to 25°C.*

This is a medication package containing 120 orally disintegrating tablets of Aripiprazole, a medication used for the treatment of mental/mood disorders such as bipolar disorder or schizophrenia. The medication is manufactured by Square Pharmaceuticals Ltd located in Dhaka, Bangladesh, and each tablet contains 20 mg of Arpiprazole USP. The package includes a medication guide that should be provided to each patient by the pharmacist. It is important to keep this medication out of the reach of children and to store it in a tight container at a temperature of 20° to 25°C (68° to 77°F). The text also warns that the medication may contain phenylalanine, a component of aspartame, and includes usual dosage information.*

This is a description for Aripiprazole Orally Disintegrating Tablets, USP manufactured by Square Pharmaceuticals Ltd. in Bangladesh. The tablets come in a package of 30 and each tablet contains 30mg of Aripiprazole USP. A medication guide should be dispensed by the pharmacist to each patient along with the tablets. The package insert should be consulted for complete prescribing information and the tablets should be stored between 20° to 25°C (66° to 77°F). The tablets are for prescription use only and should be kept in a tight container out of the reach of children. There is a warning for phenylketonurics as the tablets contain 3.3mg of phenylalanine per tablet. However, some of the text is not available.*

This is a medication bottle of Aripiprazole Orally Disintegrating Tablets, USP manufactured by Square Pharmaceuticals in Bangladesh. It contains 60 tablets of 30mg each and is intended for prescription use. The bottle also includes a medication guide for pharmacists to give to patients. The tablets contain phenylalanine, a component of aspartame, and should be stored in a tight container at room temperature. The dosage information can be found in the package insert. The label includes a warning to keep all drugs out of the reach of children. The text in the bottom right corner is not readable.*

This is a medication package containing 90 orally disintegrating tablets of 30mg Aripiprazole, manufactured by Square Pharmaceuticals Ltd. in Bangladesh. The package includes instructions for the pharmacist to provide each patient with a medication guide. The tablets contain phenylalanine and must be dispensed in a tightly sealed container. Usual dosage and complete prescribing information are provided in the package insert. The medication should be stored in a temperature-controlled space and kept away from children.*

This is a description of a medication called Aripiprazole, manufactured by Square Pharmaceuticals Ltd. The medication is in the form of orally disintegrating tablets, contains 30 mg of Arpiprazole and is dispensed in a container with 120 tablets. The package contains a medication guide to be dispensed to each patient. The medication is for prescription use only and should be stored at 20° to 25°C (68° to 77°F). The text also includes a warning to keep the medication out of reach of children, and that each tablet contains 3.3 mg phenylalanine, a component of aspartame. There is also a reference to a package insert for complete prescribing information, and a revision date of Rev.07/21.*